Clinical Trials Sponsored by Cancer Advances Inc.

Total 4512 results

UNC Lineberger Comprehensive Cancer Center

Completed

Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer

Invasive Bladder Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Terminated

Radiation Induced Cardiopulmonary Injury in Humans

Thoracic | Pulmonary Injury | Heart Injuries

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions

Neoplasm

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients

Prostate Cancer | Bladder Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer

Bladder Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation

Malignant Solid Tumour | Hematologic Malignancies | Planned Hematopoietic Cell Transplantation

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers

Non-ovarian Gynecological Cancers

United States
UNC Lineberger Comprehensive Cancer Center

Terminated

FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Pancreatic Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer (NRR)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Terminated

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC (LCCC1407)

Stage IIIA Non-Small Cell Lung Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer

Kidney Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Exercise and Quality of Life in Leukemia Patients (EQUAL)

Acute Leukemia

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to Heart

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Terminated

Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer

Prostate Cancer

United States
UNC Lineberger Comprehensive Cancer Center

Withdrawn

Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease

Breast Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); American Cancer Society, Inc.

Recruiting

Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Lung Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); American Cancer Society, Inc.

Completed

Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
Ohio State University Comprehensive Cancer Center
ImmunoGen, Inc.; Clovis Oncology, Inc.

Active, not recruiting

Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

BRCA1 Gene Mutation | BRCA2 Gene Mutation | Folate Receptor Alpha Positive | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Recurrent Uterine Serous Carcinoma | Recurrent Uterine Carcinosarcoma | Platinum...

United States
Biomedical Advanced Research and Development Authority
Rho Federal Systems Division, Inc.; ICON plc

Recruiting

Anthrax AV7909 Boost Evaluation Study (ABESt)

Anthrax

United States
University of California, Los Angeles
Defense Advanced Research Projects Agency; Defense Group, Inc.

Completed

PTSD Affect Labeling Study

Post-traumatic Stress Disorder | Post-Traumatic Stress Disorder, Chronic

United States
Advanced Cooling Therapy, Inc., d/b/a Attune Medical
Dnipropetrovsk State Medical Academy

Completed

Prospective, Interventional Study Evaluating the Feasibility and Safety of the Esophageal Cooling Device

Traumatic Brain Injury

Ukraine
Amaila Fazal [afazal]
University of Karachi

Recruiting

The Surface EMG Biofeedback as an Alternative Therapy to Reduce Chronic Low Back Pain

Chronic Low Back Pain

Pakistan
Carolinas Center for Advanced Management of Pain
Abbott Medical Devices

Completed

Optimal Stimulation Programming for Spinal Peripheral Neuromodulation

Chronic Pain

United States
Womack Army Medical Center
The Geneva Foundation; Telemedicine & Advanced Technology Research Center

Terminated

Efficacy of BFR Training Combined With Eccentric Exercise as Assessed by SWE in Subjects With Chronic AT

Achilles Tendinopathy

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; American...

Recruiting

Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm

United States
Dr. Robert F. Casper

Withdrawn

Statins: A New Therapeutic Option for Treatment of Patients With Endometriosis

Endometriosis

Canada
Asan Medical Center
Korea Advanced Institute of Science and Technology

Terminated

Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)

Kidney Transplantation

Korea, Republic of
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals, Inc.; Karyopharm Therapeutics Inc

Completed

A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma

Multiple Myeloma | Relapsed and/or Refractory Multiple Myeloma

United States
UNC Lineberger Comprehensive Cancer Center
Conquer Cancer Foundation

Completed

Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma

Multiple Myeloma | Myeloma | Disability Physical | Disabilities Multiple

United States
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Recruiting

An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer Survivors

Breast Cancer

United States
University of Michigan Rogel Cancer Center
Genentech, Inc.

Not yet recruiting

A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia

Secondary Acute Myeloid Leukemia

United States
Memorial Sloan Kettering Cancer Center
Iovance Biotherapeutics, Inc.

Recruiting

Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Metastatic Uveal Melanoma

Melanoma | Metastatic Melanoma | Metastatic Uveal Melanoma | Uveal Melanoma

United States
Memorial Sloan Kettering Cancer Center
Astex Pharmaceuticals, Inc.

Recruiting

A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)

Malignant Peripheral Nerve Sheath Tumors (MPNST)

United States
National Cancer Center Hospital East
Alpha-A, Inc.

Recruiting

Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection (ALTAIR)

Colorectal Neoplasms | Circulating Tumor DNA | Trifluridine and Tipiracil

Japan, Taiwan
Endomagnetics Inc
M.D. Anderson Cancer Center

Recruiting

Magseed Enabled Long-Term Localization of Axillary Lymph Nodes (MAGELLAN)

Breast Cancer | Axillary Lymph Nodes

United States
M.D. Anderson Cancer Center
AstraZeneca; Aravive Biologics Inc

Active, not recruiting

AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditions

United States
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study

Multiple Myeloma | High Risk Smoldering Multiple Myeloma

United States
Abramson Cancer Center at Penn Medicine
Xencor, Inc.

Active, not recruiting

XmAb20717 in Advanced Biliary Tract Cancers

Biliary Tract Cancer

United States
Memorial Sloan Kettering Cancer Center
Puma Biotechnology, Inc.

Active, not recruiting

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
AstraZeneca; Genentech, Inc.

Active, not recruiting

A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Abramson Cancer Center at Penn Medicine
ImaginAb, Inc.

Enrolling by invitation

Zr89 + PET Companion Trial

Melanoma (Skin)

United States
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Completed

Variation in Cancer Centers' End-of-Life Quality

Advanced Cancer

United States
M.D. Anderson Cancer Center
Genentech, Inc.; OSI Pharmaceuticals

Completed

Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy

Liver Cancer

United States
Fox Chase Cancer Center
Genentech, Inc.; OSI Pharmaceuticals

Completed

Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D

Non-Small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
Progenics Pharmaceuticals, Inc.

Completed

Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Prostate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)

United States
Vanderbilt University Medical Center
American Cancer Society, Inc.

Completed

New Modalities for Detection of Oropharyngeal Cancer

Oropharynx Cancer | Tonsil Cancer | Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | Base of Tongue Carcinoma

United States
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Completed

Reducing Disability in Older Adult Cancer Survivors

Cancer

United States
Ohio State University Comprehensive Cancer Center
Genentech, Inc.

Completed

OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Memorial Sloan Kettering Cancer Center
Sanofi; Genentech, Inc.

Completed

Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma

Stomach Neoplasms | Esophageal Neoplasms

United States

Clinical Trials Sponsored by Cancer Advances Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations